Cohen Yuval
Insider CIK 1626003 · CRBP Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2026-08-07 | 2026-08-10 | 17,000 | $10.08 | $171.4K | 157,316 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2026-08-07 | 2026-08-10 | 17,000 | $10.08 | $171.4K | 157,316 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2026-02-13 | 2026-02-18 | 13,871 | $7.78 | $107.9K | 174,316 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2026-01-14 | 2026-01-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2026-01-14 | 2026-01-16 | 50,000 | — | $0 | 188,187 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2025-10-27 | 2025-10-27 | 8,973 | — | $0 | 22,106 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2025-10-27 | 2025-10-27 | 8,973 | $4.26 | $38.2K | 147,160 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2025-10-27 | 2025-10-27 | 8,973 | $17.14 | $153.8K | 138,187 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2025-10-24 | 2025-10-27 | 18,660 | — | $0 | 31,079 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2025-10-24 | 2025-10-27 | 18,660 | $4.26 | $79.5K | 156,847 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2025-10-24 | 2025-10-27 | 18,660 | $17.01 | $317.4K | 138,187 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2025-02-14 | 2025-02-18 | 7,134 | $8.76 | $62.5K | 138,187 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2025-01-31 | 2025-02-04 | 228,800 | — | $0 | 228,800 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2025-01-31 | 2025-02-04 | 68,100 | — | $0 | 145,321 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-18 | 2024-06-18 | 1,770 | — | $0 | 31,057 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-18 | 2024-06-18 | 11,667 | — | $0 | 0 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-18 | 2024-06-18 | 2,322 | — | $0 | 49,739 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-18 | 2024-06-18 | 7,179 | $42.24 | $303.2K | 77,221 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-18 | 2024-06-18 | 1,770 | $14.10 | $25.0K | 86,170 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-18 | 2024-06-18 | 1,770 | $42.24 | $74.8K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-18 | 2024-06-18 | 2,322 | $4.26 | $9.9K | 86,722 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-18 | 2024-06-18 | 2,322 | $42.24 | $98.1K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-18 | 2024-06-18 | 11,667 | $42.24 | $492.8K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-18 | 2024-06-18 | 11,667 | $30.00 | $350.0K | 96,067 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-17 | 2024-06-18 | 1,770 | — | $0 | 52,061 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-17 | 2024-06-18 | 9,333 | — | $0 | 11,667 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-17 | 2024-06-18 | 9,333 | $30.00 | $280.0K | 93,733 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-17 | 2024-06-18 | 1,770 | $46.02 | $81.5K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-17 | 2024-06-18 | 9,333 | $46.02 | $429.5K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-17 | 2024-06-18 | 1,770 | $4.26 | $7.5K | 86,170 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-14 | 2024-06-18 | 12,487 | — | $0 | 53,831 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-06-14 | 2024-06-18 | 16,830 | — | $0 | 32,827 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-14 | 2024-06-18 | 16,830 | $14.10 | $237.3K | 101,230 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-14 | 2024-06-18 | 16,830 | $50.17 | $844.4K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-06-14 | 2024-06-18 | 12,487 | $4.26 | $53.2K | 96,887 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2024-06-14 | 2024-06-18 | 12,487 | $50.17 | $626.5K | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2024-02-12 | 2024-02-14 | 73,947 | — | $0 | 73,947 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2024-02-12 | 2024-02-14 | 73,947 | — | $0 | 84,400 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2024-01-26 | 2024-01-30 | 7,179 | $4.97 | $35.7K | 0 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2024-01-26 | 2024-01-30 | 7,179 | $4.97 | $35.7K | 7,179 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2023-02-13 | 2023-02-15 | 1,989,546 | — | $0 | 1,949,546 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2022-08-10 | 2022-08-11 | 3,800 | $0.26 | $988 | 98,230 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2022-05-16 | 2022-05-16 | 10,500 | $0.25 | $2.6K | 94,430 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2022-03-09 | 2022-03-09 | 8,600 | $0.37 | $3.2K | 83,930 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2022-02-01 | 2022-02-02 | 1,489,700 | — | $0 | 1,489,700 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2021-02-02 | 2021-02-04 | 956,500 | — | $0 | 956,500 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2021-02-02 | 2021-02-04 | 956,500 | — | $0 | 956,500 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2020-11-11 | 2020-11-12 | 4,240 | $1.21 | $5.1K | 75,330 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2020-03-17 | 2020-03-17 | 4,300 | $3.49 | $15.0K | 71,090 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2020-03-06 | 2020-03-09 | 639,000 | — | $0 | 639,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2019-11-12 | 2019-11-12 | 1,430 | $4.26 | $6.1K | 66,790 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2019-08-12 | 2019-08-12 | 1,175 | $6.06 | $7.1K | 65,360 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2019-05-13 | 2019-05-14 | 995 | $6.99 | $7.0K | 64,185 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2019-03-14 | 2019-03-14 | 1,530 | $6.49 | $9.9K | 63,190 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2019-01-18 | 2019-01-18 | 565,000 | — | $0 | 565,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2018-05-15 | 2018-05-16 | 1,725 | $5.85 | $10.1K | 61,660 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2018-03-14 | 2018-03-15 | 1,160 | $6.89 | $8.0K | 59,935 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2018-01-04 | 2018-01-05 | 437,500 | — | $0 | 437,500 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2017-11-10 | 2017-11-13 | 1,000 | $7.17 | $7.2K | 58,775 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2017-08-11 | 2017-08-11 | 1,695 | $6.00 | $10.2K | 57,775 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2017-05-11 | 2017-05-12 | 3,250 | $6.01 | $19.5K | 56,080 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2017-03-16 | 2017-03-17 | 20,000 | $1.00 | $20.0K | 272,728 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2017-03-16 | 2017-03-17 | 20,000 | $1.00 | $20.0K | 52,830 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2017-03-01 | 2017-03-03 | 377,500 | — | $0 | 377,500 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2016-11-22 | 2017-01-20 | 1,340 | $7.64 | $10.2K | 32,830 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2016-11-22 | 2016-11-23 | 1,340 | $7.64 | $10.2K | 12,830 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2016-10-06 | 2016-10-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise deriv | 2016-08-17 | 2016-08-18 | 20,000 | $1.00 | $20.0K | 292,728 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | M Exercise | 2016-08-17 | 2016-08-18 | 20,000 | $1.00 | $20.0K | 31,490 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2016-06-06 | 2016-06-07 | 1,500 | $3.34 | $5.0K | 11,490 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2016-05-18 | 2016-05-19 | 2,125 | $2.40 | $5.1K | 9,990 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2016-01-07 | 2016-01-11 | 530,000 | — | $0 | 530,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2015-11-23 | 2015-11-24 | 535 | $1.76 | $942 | 6,835 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2015-11-13 | 2015-11-16 | 850 | $1.73 | $1.5K | 6,300 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2015-08-24 | 2015-08-25 | 550 | $1.95 | $1.1K | 5,450 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2015-08-17 | 2015-08-18 | 1,025 | $1.94 | $2.0K | 3,825 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2015-08-17 | 2015-08-18 | 1,075 | $1.90 | $2.0K | 4,900 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2015-06-15 | 2015-06-15 | 900 | $3.28 | $3.0K | 2,800 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2014-12-17 | 2014-12-18 | 400 | $3.66 | $1.5K | 1,900 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2014-12-04 | 2014-12-04 | 500 | $3.30 | $1.6K | 1,500 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | P Buy | 2014-12-03 | 2014-12-04 | 1,000 | $3.20 | $3.2K | 1,000 | SEC↗ |